{"DataElement":{"publicId":"13212141","version":"1","preferredName":"Medical History Relevant Condition Type","preferredDefinition":"The identifiable class of injuries, disabilities, syndromes, or symptoms found in an individual's health background.","longName":"13209562v1.00:13139257v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13209562","version":"1","preferredName":"Medical History Relevant Condition","preferredDefinition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.:The relation of something to the matter at hand._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"2431097v1.00:13209561v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2431097","version":"1","preferredName":"Personal Medical History","preferredDefinition":"an account of all medical events and problems a person has experienced.","longName":"C18772","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Personal Medical History","conceptCode":"C18772","definition":"A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF61-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13209561","version":"1","preferredName":"Relevance Disease or Disorder","preferredDefinition":"The relation of something to the matter at hand._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C70664:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relevance","conceptCode":"C70664","definition":"The relation of something to the matter at hand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7563D27-6B80-7606-E053-731AD00A710A","latestVersionIndicator":"Yes","beginDate":"2023-03-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-20","modifiedBy":"COLBERTM","dateModified":"2023-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7563D27-6B81-7606-E053-731AD00A710A","latestVersionIndicator":"Yes","beginDate":"2023-03-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-20","modifiedBy":"FINCHAMB","dateModified":"2023-11-11","changeDescription":null,"administrativeNotes":"11/11/23 Released per PCDC-U of Chicago/Mei Li. BF;3/20/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13139257","version":"1","preferredName":"Condition Type","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Something distinguishable as an identifiable class based on common qualities","longName":"13139257v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenomatous Polyposis Coli","valueDescription":null,"ValueMeaning":{"publicId":"13162646","version":"1","preferredName":"Adenomatous Polyposis Coli Protein","longName":"13162646v1.00","preferredDefinition":"Adenomatous polyposis coli protein (2843 aa, ~312 kDa) is encoded by the human APC gene. This protein is involved in both tumor suppression and the inhibition of the Wnt signaling pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenomatous Polyposis Coli Protein","conceptCode":"C17687","definition":"Adenomatous polyposis coli protein (2843 aa, ~312 kDa) is encoded by the human APC gene. This protein is involved in both tumor suppression and the inhibition of the Wnt signaling pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F695D80E-62AB-642A-E053-731AD00AA758","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62AE-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62AF-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Bloom Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2730287","version":"1","preferredName":"Bloom Syndrome","longName":"2730287","preferredDefinition":"Bloom syndrome is an autosomal recessive disorder associated with mutations in BLM gene encoding protein that belongs to the family of DNA helicases. It is characterized by predisposition to cancer, immunodeficiency, high sensitivity to UV and genomic instability of somatic cells. (Oncogene 2001 Dec 13;20(57):8276-80)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bloom Syndrome","conceptCode":"C2903","definition":"Bloom syndrome is an autosomal recessive disorder associated with mutations in BLM gene encoding protein that belongs to the family of DNA helicases. It is characterized by predisposition to cancer, immunodeficiency, high sensitivity to UV and genomic instability of somatic cells. (Oncogene 2001 Dec 13;20(57):8276-80)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"468669DD-2FE6-4A98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B0-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Celiac Disease","valueDescription":null,"ValueMeaning":{"publicId":"3249580","version":"1","preferredName":"Celiac Disease","longName":"3249580","preferredDefinition":"A digestive disease that is caused by an immune response to a protein called gluten, which is found in wheat, rye, barley, and oats. Celiac disease damages the lining of the small intestine and interferes with the absorption of nutrients from food. A person with celiac disease may become malnourished no matter how much food is consumed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Celiac Disease","conceptCode":"C26714","definition":"An autoimmune genetic disorder with an unknown pattern of inheritance that primarily affects the digestive tract. It is caused by intolerance to dietary gluten. Consumption of gluten protein triggers an immune response which damages small intestinal villi and prevents adequate absorption of nutrients. Clinical signs include abdominal cramping, diarrhea or constipation and weight loss. If untreated, the clinical course may progress to malnutrition, anemia, osteoporosis and an increased risk of intestinal malignancies. However, the prognosis is favorable with successful avoidance of gluten in the diet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D99025-BE2B-DBB4-E040-BB89AD434418","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B1-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Central Hypoventilation Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"13162648","version":"1","preferredName":"Congenital Central Hypoventilation","longName":"13162648v1.00","preferredDefinition":"A disorder characterized by hypoventilation and hypoxemia. It appears early in life and is not associated with cardiopulmonary or neuromuscular abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Central Hypoventilation ","conceptCode":"C98889","definition":"A disorder characterized by hypoventilation and hypoxemia. It appears early in life and is not associated with cardiopulmonary or neuromuscular abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F695D80E-62AD-642A-E053-731AD00AA758","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B2-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Cherubism","valueDescription":null,"ValueMeaning":{"publicId":"3210953","version":"1","preferredName":"Cherubism","longName":"3210953","preferredDefinition":"A rare disorder usually caused by mutations in the SH3BP2 gene. It is characterized by prominence of the lower part of the face due to bilateral replacement of the mandible or maxilla bones by excessive fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cherubism","conceptCode":"C84630","definition":"A rare autosomal dominant inherited disorder usually caused by mutations in the SH3BP2 gene. It is characterized by a prominent lower part of the face due to bilateral replacement of the mandibular or maxillary bones by lesions. The lesions contain osteoclast-like cells admixed with spindle-shaped mononuclear stromal cells.  With time, the lesions become more fibrotic and less osteoclast-rich.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B930-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B3-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Cleft Lip","valueDescription":null,"ValueMeaning":{"publicId":"4920016","version":"1","preferredName":"Cleft Lip","longName":"4920016","preferredDefinition":"A congenital abnormality consisting of one or more clefts (splits) in the upper lip, which may be accompanied by a cleft palate; it is the result of the failure of the embryonic parts of the lip to fuse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cleft Lip","conceptCode":"C87175","definition":"A congenital abnormality consisting of one or more clefts (splits) in the upper lip, which may be accompanied by a cleft palate; it is the result of the failure of the embryonic parts of the lip to fuse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8FCB10-6F09-B06E-E050-BB89AD430721","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B4-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Cleft Palate","valueDescription":null,"ValueMeaning":{"publicId":"4920014","version":"1","preferredName":"Cleft Palate","longName":"4920014","preferredDefinition":"A congenital abnormality consisting of a fissure in the midline of the hard and/or soft palate; it is the result of the failure of the two sides of the palate to fuse during embryonic development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cleft Palate","conceptCode":"C87069","definition":"A congenital abnormality consisting of a fissure in the midline of the hard and/or soft palate; it is the result of the failure of the two sides of the palate to fuse during embryonic development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8FCB10-6EE3-B06E-E050-BB89AD430721","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B5-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Clubfoot","valueDescription":null,"ValueMeaning":{"publicId":"3210972","version":"1","preferredName":"Clubfoot","longName":"3210972","preferredDefinition":"The most common congenital deformation of the foot, occurring in 1 of 1,000 live births. The most common form is talipes equinovarus, where the deformed foot is turned downward and inward sharply.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clubfoot","conceptCode":"C84641","definition":"The most common congenital deformation of the foot, occurring in 1 of 1,000 live births. The most common form is talipes equinovarus, where the deformed foot is turned downward and inward sharply.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BBDE-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B6-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Breast and Ovarian Cancer Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"13162647","version":"1","preferredName":"BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome","longName":"13162647v1.00","preferredDefinition":"An autosomal dominant inherited syndrome caused by deleterious mutations in the BRCA1 or BRCA2 genes. Patients are at high risk of developing breast cancer, particularly before the age of fifty, high risk of developing a second primary breast cancer, and high risk of developing both breast and ovarian cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome","conceptCode":"C8493","definition":"An autosomal dominant inherited syndrome caused by deleterious mutations in the BRCA1 or BRCA2 genes. Patients are at high risk of developing breast cancer, particularly before the age of fifty, high risk of developing a second primary breast cancer, and high risk of developing both breast and ovarian cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F695D80E-62AC-642A-E053-731AD00AA758","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F695D80E-62B7-642A-E053-731AD00AA758","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"COLBERTM","dateModified":"2024-02-14","deletedIndicator":"No"},{"value":"Costello Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3210988","version":"1","preferredName":"Costello Syndrome","longName":"3210988","preferredDefinition":"A genetic syndrome caused by mutations in the HRAS gene. It is characterized by developmental delay, mental retardation, loose skin folds, cardiomyopathy, tachycardia, and structural heart defects. Patients are at an increased risk of developing benign or malignant neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Costello Syndrome","conceptCode":"C84652","definition":"A genetic syndrome caused by mutations in the HRAS gene. It is characterized by developmental delay, mental retardation, loose skin folds, cardiomyopathy, tachycardia, and structural heart defects. Patients are at an increased risk of developing benign or malignant neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BE1A-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53D7-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Denys-Drash Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3078438","version":"1","preferredName":"Denys-Drash Syndrome ","longName":"3078438","preferredDefinition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Denys-Drash Syndrome","conceptCode":"C84668","definition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85399A6D-D19D-B88C-E040-BB89AD431518","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53D9-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Diabetes Mellitus (Type I)","valueDescription":null,"ValueMeaning":{"publicId":"5054471","version":"1","preferredName":"Type 1 Diabetes Mellitus","longName":"5054471","preferredDefinition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 1 Diabetes Mellitus","conceptCode":"C2986","definition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B65-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53DA-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Diamond-Blackfan Anemia","valueDescription":null,"ValueMeaning":{"publicId":"3199134","version":"1","preferredName":"Congenital Pure Red Cell Aplasia","longName":"3199134","preferredDefinition":"An inherited condition characterized by aplasia of the erythroid series only. The white cells and platelets are not affected. Patients develop anemia usually in infancy.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Pure Red Cell Aplasia","conceptCode":"C61236","definition":"An inherited condition characterized by aplasia of the erythroid series only. The white cells and platelets are not affected. Patients develop anemia usually in infancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DAC64CD-9F51-0F86-E040-BB89AD436AC4","latestVersionIndicator":"Yes","beginDate":"2011-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"04/13/2011 - Updated with current NCIt name for VM.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53DB-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"DICER1 Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"13162649","version":"1","preferredName":"DICER1 Syndrome","longName":"13162649v1.00","preferredDefinition":"A rare, autosomal dominant inherited syndrome caused by mutations in the DICER1 gene. People with this syndrome are at an increased risk of developing pleuropulmonary blastoma, cystic nephroma, Sertoli-Leydig cell tumor of the ovary, and multinodular goiter.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DICER1 Syndrome","conceptCode":"C123317","definition":"A rare, autosomal dominant inherited syndrome caused by mutations in the DICER1 gene. People with this syndrome are at an increased risk of developing pleuropulmonary blastoma, cystic nephroma, Sertoli-Leydig cell tumor of the ovary, and multinodular goiter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F69615F1-53D5-6B33-E053-731AD00AB7EA","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53DC-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Down Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2730288","version":"1","preferredName":"Down Syndrome","longName":"2730288","preferredDefinition":"A disorder caused by the presence of an extra chromosome 21 and characterized by mental retardation and distinguishing physical features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Down Syndrome","conceptCode":"C2993","definition":"A chromosomal dysgenesis syndrome resulting from a triplication or translocation of chromosome 21. Down syndrome occurs in approximately 1:700 live births. Abnormalities are variable from individual to individual and may include mental retardation, retarded growth, flat hypoplastic face with short nose, prominent epicanthic skin folds, small low-set ears with prominent antihelix, fissured and thickened tongue, laxness of joint ligaments, pelvic dysplasia, broad hands and feet, stubby fingers, transverse palmar crease, lenticular opacities and heart disease. Patients with Down syndrome have an estimated 10 to 30-fold increased risk for leukemia; most have symptoms of Alzheimer's disease by age 40. Also known as trisomy 21 syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"468669DD-300B-4A98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53DD-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Fanconi Anemia","valueDescription":null,"ValueMeaning":{"publicId":"5651022","version":"1","preferredName":"Fanconi Anemia","longName":"5651022","preferredDefinition":"A rare inherited disorder in which the bone marrow does not make blood cells. It is usually diagnosed in children between 2 and 15 years old. Symptoms include frequent infections, easy bleeding, and extreme tiredness. People with Fanconi anemia may have a small skeleton and brown spots on the skin. They also have an increased risk of developing certain types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fanconi Anemia","conceptCode":"C62505","definition":"An autosomal recessive genetic disorder characterized by bone marrow failure, skeletal abnormalities, and an increased incidence of the development of neoplasias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"479020AD-0CB9-3909-E053-F662850A62CA","latestVersionIndicator":"Yes","beginDate":"2017-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-02","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53DE-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Frasier Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"13162650","version":"1","preferredName":"Frasier Syndrome","longName":"13162650v1.00","preferredDefinition":"A condition, which typically presents during adolescence, that is caused by WT-1 mutation, and is characterized by a developmental sex disorder, FSGS, and may be associated with gonadoblastoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Frasier Syndrome","conceptCode":"C122805","definition":"A condition, which typically presents during adolescence, that is caused by WT-1 mutation, and is characterized by a developmental sex disorder, FSGS, and may be associated with gonadoblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F69615F1-53D6-6B33-E053-731AD00AB7EA","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53DF-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Gardner Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2577527","version":"1","preferredName":"Gardner's Syndrome","longName":"2577527","preferredDefinition":"An autosomal dominant syndrome characterised by multiple colonic polyps predisposing to carcinoma of the colon, osteomas of the skull, epidermoid cysts, and fibromas.  It is associated with mutation of the APC gene. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gardner Syndrome","conceptCode":"C6728","definition":"A variant of familial adenomatous polyposis. It is an autosomal dominant syndrome characterized by multiple colonic polyps predisposing to carcinoma of the colon, osteomas of the skull, epidermoid cysts, and fibromas. It is associated with mutation of the APC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"ONEDATA","dateModified":"2006-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69615F1-53E0-6B33-E053-731AD00AB7EA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Gastroschisis","valueDescription":null,"ValueMeaning":{"publicId":"3211093","version":"1","preferredName":"Gastroschisis","longName":"3211093","preferredDefinition":"A congenital birth defect characterized by the exposure of the fetal intestines outside the abdominal wall through an abdominal wall opening.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroschisis","conceptCode":"C84725","definition":"A congenital birth defect characterized by the exposure of the fetal intestines outside the abdominal wall through an abdominal wall opening.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-CCCE-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07AD-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Gonadal Dysgenesis","valueDescription":null,"ValueMeaning":{"publicId":"13162651","version":"1","preferredName":"Gonadal Dysgenesis","longName":"13162651v1.00","preferredDefinition":"A congenital disorder characterized by the presence of extremely hypoplastic gonads preventing the development of secondary sex characteristics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gonadal Dysgenesis","conceptCode":"C61420","definition":"A congenital disorder characterized by the presence of extremely hypoplastic gonads preventing the development of secondary sex characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6966B47-07AB-782E-E053-731AD00A2D4D","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07AE-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Goodpasture's Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"5417298","version":"1","preferredName":"Goodpasture syndrome","longName":"5417298","preferredDefinition":"An autoimmune disorder characterized by pulmonary hemorrhage and glomerulonephritis. It is a hypersensitivity reaction resulting in the formation of antibodies against the pulmonary alveoli and the basement membrane of the glomeruli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Goodpasture Syndrome","conceptCode":"C34649","definition":"An autoimmune disorder characterized by pulmonary hemorrhage and glomerulonephritis. It is a hypersensitivity reaction resulting in the formation of antibodies against the pulmonary alveoli and the basement membrane of the glomeruli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-42F4-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07AF-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Gorlin Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3210902","version":"1","preferredName":"Nevoid Basal Cell Carcinoma Syndrome","longName":"3210902","preferredDefinition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH gene.  It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida).  Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nevoid Basal Cell Carcinoma Syndrome","conceptCode":"C2892","definition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH and SUFU gene. It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida). Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B1D8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07B0-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Graves' Disease","valueDescription":null,"ValueMeaning":{"publicId":"5417297","version":"1","preferredName":"Graves disease","longName":"5417297","preferredDefinition":"Hyperthyroidism associated with diffuse hyperplasia of the thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells. As a result, the thyroid gland enlarges and secrets increased amounts of thyroid hormones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graves Disease","conceptCode":"C3071","definition":"Hyperthyroidism associated with diffuse hyperplasia of the thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells. As a result, the thyroid gland enlarges and secretes increased amounts of thyroid hormones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-42D1-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07B1-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Hashimoto's Thyroiditis","valueDescription":null,"ValueMeaning":{"publicId":"5417296","version":"1","preferredName":"Hashimoto thyroiditis","longName":"5417296","preferredDefinition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hashimoto Thyroiditis","conceptCode":"C27191","definition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-42AE-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07B2-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Heart Defect","valueDescription":null,"ValueMeaning":{"publicId":"13162652","version":"1","preferredName":"Genetic Syndrome Associated with Congenital Heart Defect","longName":"13162652v1.00","preferredDefinition":"Genetic anomalies and collections of malformations that are known to cluster together that can be associated with congenital heart defects. (ACC/AHA)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Syndrome Associated with Congenital Heart Defect","conceptCode":"C168217","definition":"Genetic anomalies and collections of malformations that are known to cluster together that can be associated with congenital heart defects. (ACC/AHA)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6966B47-07AC-782E-E053-731AD00A2D4D","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07B3-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Hemihypertrophy","valueDescription":null,"ValueMeaning":{"publicId":"3078440","version":"1","preferredName":"Hemihypertrophy","longName":"3078440","preferredDefinition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemihypertrophy","conceptCode":"C88541","definition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85399A6D-D1E3-B88C-E040-BB89AD431518","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6966B47-07B4-782E-E053-731AD00A2D4D","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Inflammatory Bowel Disease","valueDescription":null,"ValueMeaning":{"publicId":"5417294","version":"1","preferredName":"Inflammatory bowel disease","longName":"5417294","preferredDefinition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Bowel Disease","conceptCode":"C3138","definition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-4268-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-703A-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Juvenile Idiopathic Arthritis","valueDescription":null,"ValueMeaning":{"publicId":"13162653","version":"1","preferredName":"Juvenile Idiopathic Arthritis","longName":"13162653v1.00","preferredDefinition":"A group of chronic, inflammatory childhood disorders of unknown etiology that primarily involve joints.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juvenile Idiopathic Arthritis","conceptCode":"C114357","definition":"A group of chronic, inflammatory childhood disorders of unknown etiology that primarily involve joints.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F69689FF-7038-7C2B-E053-731AD00A7A36","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-703B-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Klinefelter Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211203","version":"1","preferredName":"Klinefelter Syndrome","longName":"3211203","preferredDefinition":"A sex chromosome disorder caused by the presence of an extra X chromosome in the male karyotype. Affected individuals are infertile and have a small penis and testes. They tend to have tall stature and long legs and may have difficulties with speech and language development. Gynecomastia may be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Klinefelter Syndrome","conceptCode":"C34752","definition":"A sex chromosome disorder caused by the presence of an extra X chromosome in the male karyotype. Affected individuals are infertile and have a small penis and testes. They tend to have tall stature and long legs and may have difficulties with speech and language development. Gynecomastia may be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DC57-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-703C-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-14","deletedIndicator":"No"},{"value":"Li-Fraumeni Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211225","version":"1","preferredName":"Li-Fraumeni Syndrome","longName":"3211225","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by an alteration in the p53 tumor suppressor gene.  It is characterized by the development of malignant neoplasms at various anatomic sites.  The malignant neoplasms associated with Li-Fraumeni syndrome include adrenal cortex carcinoma, astrocytic tumors, colorectal carcinoma, gastric carcinoma, malignant breast neoplasms, medulloblastoma, osteosarcoma, and soft tissue sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Li-Fraumeni Syndrome","conceptCode":"C3476","definition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the TP53 gene. It is associated with breast carcinoma, choroid plexus carcinoma, adrenal cortex carcinoma, astrocytic tumors, medulloblastoma, soft tissue sarcoma, osteosarcoma, and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DF6B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-703D-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Lynch Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2716424","version":"1","preferredName":"Hereditary Non-Polyposis Colon Cancer","longName":"2716424","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma.  Patients often develop colorectal carcinomas at an early age (mean, 45 years).  In the majority of the cases the lesions arise from the proximal colon.  At the molecular level, high-frequency microsatellite instability is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lynch Syndrome","conceptCode":"C8494","definition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41B659B0-44F3-5521-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-703E-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Maffucci Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"4824456","version":"1","preferredName":"Maffucci Syndrome","longName":"4824456","preferredDefinition":"A rare non-inherited disorder primarily affecting the skin and skeletal system. It is classified as a mesodermal dysplasia. Clinical signs appear within the first decade and are characterized by multiple soft tissue hemiangiomas and enchondromas leading to skeletal deformities. Clinical course is progressive with variable development of associated malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maffucci Syndrome","conceptCode":"C3213","definition":"A rare non-inherited disorder primarily affecting the skin and skeletal system. It is classified as a mesodermal dysplasia. Clinical signs appear within the first decade and are characterized by multiple soft tissue hemiangiomas and enchondromas leading to skeletal deformities. Clinical course is progressive with variable development of associated malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-44E0-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-703F-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"McCune-Albright Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"13162654","version":"1","preferredName":"McCune-Albright Syndrome","longName":"13162654v1.00","preferredDefinition":"A syndrome characterized by the presence of polyostotic fibrous dysplasia, cafe-au-lait skin lesions, and sexual precocity.  It is caused by mutations within the GNAS genetic locus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"McCune-Albright Syndrome","conceptCode":"C48627","definition":"A syndrome characterized by the presence of polyostotic fibrous dysplasia, cafe-au-lait skin lesions, and sexual precocity.  It is caused by mutations within the GNAS genetic locus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F69689FF-7039-7C2B-E053-731AD00A7A36","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-7040-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Mixed Connective Tissue Disease","valueDescription":null,"ValueMeaning":{"publicId":"3211258","version":"1","preferredName":"Mixed Connective Tissue Disease","longName":"3211258","preferredDefinition":"An autoimmune overlap syndrome characterized by the presence of symptoms of systemic lupus erythematosus, systemic scleroderma, and polymyositis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Connective Tissue Disease","conceptCode":"C84892","definition":"An autoimmune overlap syndrome characterized by the presence of symptoms of systemic lupus erythematosus, systemic scleroderma, and polymyositis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E423-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-7041-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Multiple Osteochondromas","valueDescription":null,"ValueMeaning":{"publicId":"3211273","version":"1","preferredName":"Multiple Osteochondromas","longName":"3211273","preferredDefinition":"A neoplastic chondrogenic process affecting multiple sites. Grossly and microscopically it resembles an osteochondroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Osteochondromas","conceptCode":"C53457","definition":"An autosomal dominant neoplastic chondrogenic process affecting multiple sites. It is caused by mutations in the EXT1 or EXT2 genes.  Grossly and microscopically, the lesions resemble an osteochondroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E6A1-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-7042-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Multiple Sclerosis","valueDescription":null,"ValueMeaning":{"publicId":"2760060","version":"1","preferredName":"Multiple Sclerosis","longName":"2760060","preferredDefinition":"A disorder of the central nervous system marked by weakness, numbness, a loss of muscle coordination, and problems with vision, speech, and bladder control. Multiple sclerosis is thought to be an autoimmune disease in which the body's immune system destroys myelin. Myelin is a substance that contains both protein and fat (lipid), serving as a nerve insulator and helping in the transmission of nerve signals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Sclerosis","conceptCode":"C3243","definition":"A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FE4369C-D09F-4E65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F69689FF-7043-7C2B-E053-731AD00A7A36","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Neurofibromatosis Type 1","valueDescription":null,"ValueMeaning":{"publicId":"2962080","version":"1","preferredName":"Neurofibromatosis Type 1","longName":"2962080","preferredDefinition":"Type 1 (peripheral) neurofibromatosis (von Recklinghausen's disease), is the most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath neoplasms, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 1","conceptCode":"C3273","definition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A8D-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"GDEEN","dateModified":"2023-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C122-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Neurofibromatosis Type 2","valueDescription":null,"ValueMeaning":{"publicId":"2962078","version":"1","preferredName":"Neurofibromatosis Type 2","longName":"2962078","preferredDefinition":"An autosomal dominant disorder caused by mutations in the NF2 tumor suppressor gene.  It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 2","conceptCode":"C3274","definition":"An autosomal dominant disorder caused by mutations in the NF2 tumor suppressor gene.  It is characterized by the development of peripheral and central nervous system tumors including acoustic schwannomas, neurofibromas, gliomas, and meningiomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A67-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"GDEEN","dateModified":"2023-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C123-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Noonan Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211308","version":"1","preferredName":"Noonan Syndrome","longName":"3211308","preferredDefinition":"A genetic syndrome caused by mutations in the PTPN11 gene (over 50% of the cases) or less frequently mutations in the SOS1, RAF1, or KRAS genes.  It is characterized by short stature, webbed neck, hypertelorism, low-set ears, deafness, and thrombocytopenia or abnormal platelet function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Noonan Syndrome","conceptCode":"C34854","definition":"A genetic syndrome caused by mutations in the PTPN11 gene (over 50% of the cases) or less frequently mutations in the SOS1, RAF1, or KRAS genes. It is characterized by short stature, webbed neck, hypertelorism, low-set ears, deafness, and thrombocytopenia or abnormal platelet function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EBD3-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C124-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Ollier Disease","valueDescription":null,"ValueMeaning":{"publicId":"3211042","version":"1","preferredName":"Enchondromatosis","longName":"3211042","preferredDefinition":"A rare benign disorder characterized by lack of normal endchondral ossification, and the growth of multiple enchondromas.  It primarily affects the bones of the hand, in children and young adults.  Extent of the disease varies; in some cases, neoplastic involvement may be wide spread causing considerable deformity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enchondromatosis","conceptCode":"C3008","definition":"A rare benign disorder characterized by lack of normal endochondral ossification, and the growth of multiple enchondromas.  It primarily affects the bones of the hand, in children and young adults.  Extent of the disease varies; in some cases, neoplastic involvement may be widespread causing considerable deformity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C598-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C125-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Paget Disease","valueDescription":null,"ValueMeaning":{"publicId":"3251708","version":"1","preferredName":"Paget's Disease","longName":"3251708","preferredDefinition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget's cell neoplasms include Paget's disease of the nipple and extramammary Paget's disease which may affect the vulva, penis, anus, skin and scrotum. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paget Disease","conceptCode":"C7073","definition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D61A-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C126-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Psoriasis","valueDescription":null,"ValueMeaning":{"publicId":"4276834","version":"1","preferredName":"Psoriasis","longName":"4276834","preferredDefinition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Psoriasis","conceptCode":"C3346","definition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7A209D6-78D6-98DB-E040-BB89AD4339B1","latestVersionIndicator":"Yes","beginDate":"2014-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C127-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Retinoblastoma","valueDescription":null,"ValueMeaning":{"publicId":"4265254","version":"1","preferredName":"Retinoblastoma","longName":"4265254","preferredDefinition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retinoblastoma","conceptCode":"C7541","definition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4BEC-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C128-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Rothmund-Thomson Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211425","version":"1","preferredName":"Rothmund-Thomson Syndrome","longName":"3211425","preferredDefinition":"An autosomal recessive inherited syndrome usually caused by mutations in the RECQL4 gene. It is characterized by poikilodermatous skin changes, sparse hair, cataracts, small stature, skeletal abnormalities, and an increased predisposition to cancer, particularly osteosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rothmund-Thomson Syndrome","conceptCode":"C3335","definition":"An autosomal recessive inherited syndrome usually caused by mutations in the RECQL4 gene. It is characterized by poikilodermatous skin changes, sparse hair, cataracts, small stature, skeletal abnormalities, and an increased predisposition to cancer, particularly osteosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FBF5-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C129-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Scleroderma","valueDescription":null,"ValueMeaning":{"publicId":"2593560","version":"1","preferredName":"Scleroderma","longName":"2593560","preferredDefinition":"A chronic disorder marked by hardening and thickening of the skin.  Scleroderma can be localized or it can affect the entire body (systemic).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scleroderma","conceptCode":"C26746","definition":"A localized or systemic chronic and progressive autoimmune disorder characterized by thickening of the skin and the connective tissues. Localized scleroderma affects only the skin. Systemic scleroderma affects internal organs, including the heart, lungs, gastrointestinal tract, and kidneys.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BED1B6-B07C-6CBF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696A423-C12A-09E9-E053-731AD00A0957","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Swyer Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211465","version":"1","preferredName":"Swyer James Syndrome","longName":"3211465","preferredDefinition":"A rare syndrome characterized by the presence of a small lung as a result of unilateral post-infectious bronchiolitis obliterans.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Swyer James Syndrome","conceptCode":"C85178","definition":"A rare syndrome characterized by the presence of a small lung as a result of unilateral post-infectious bronchiolitis obliterans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-01DD-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF81-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Trisomy 21","valueDescription":null,"ValueMeaning":{"publicId":"2762291","version":"1","preferredName":"Trisomy 21","longName":"2762291","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 21 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 21","conceptCode":"C43224","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 21 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-00ED-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF83-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Trisomy 21 Mosaicism","valueDescription":null,"ValueMeaning":{"publicId":"6042513","version":"1","preferredName":"Trisomy 21 Mosaicism","longName":"6042513","preferredDefinition":"The presence of cells with and without three copies of chromosome 21 in either somatic or germinal tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 21 Mosaicism","conceptCode":"C142099","definition":"The presence of cells with and without three copies of chromosome 21 in either somatic or germinal tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"604F6BE6-7B45-5DBE-E053-F662850ABBE7","latestVersionIndicator":"Yes","beginDate":"2017-12-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-12-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF84-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Turner Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211505","version":"1","preferredName":"Turner Syndrome","longName":"3211505","preferredDefinition":"A gonadal dysgenesis syndrome occurring in phenotypic females, characterized by the absence of a part or all of one of the sex chromosomes. Signs and symptoms include short stature, webbing of neck, low-set ears, hypogonadism, and sterility.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Turner Syndrome","conceptCode":"C26900","definition":"A gonadal dysgenesis syndrome occurring in phenotypic females, characterized by the absence of a part or all of one of the sex chromosomes. Signs and symptoms include short stature, webbing of neck, low-set ears, hypogonadism, and sterility.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-07D5-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF85-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Vitiligo","valueDescription":null,"ValueMeaning":{"publicId":"3252121","version":"1","preferredName":"Vitiligo","longName":"3252121","preferredDefinition":"A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vitiligo","conceptCode":"C26915","definition":"Generalized well circumscribed patches of leukoderma that are generally distributed over symmetric body locations and is due to autoimmune destruction of melanocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A781D14A-E71E-8A44-E040-BB89AD4310FD","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF86-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"WAGR Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3078439","version":"1","preferredName":"WAGR Syndrome","longName":"3078439","preferredDefinition":"A very rare congenital condition involving the complex of Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WAGR Syndrome","conceptCode":"C3718","definition":"A very rare congenital condition involving the complex of Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85399A6D-D1C0-B88C-E040-BB89AD431518","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF87-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Werner Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"4824452","version":"1","preferredName":"Werner Syndrome","longName":"4824452","preferredDefinition":"A rare, autosomal recessive syndrome caused by mutations in the WRN gene. It is characterized by the appearance of accelerated aging following puberty. It is associated with the development of diabetes mellitus, atherosclerosis, cataracts, and cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Werner Syndrome","conceptCode":"C3447","definition":"A rare, autosomal recessive syndrome caused by mutations in the WRN gene. It is characterized by the appearance of accelerated aging following puberty. It is associated with the development of diabetes mellitus, atherosclerosis, cataracts, and cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-444B-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF88-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF89-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"4266671","version":"1","preferredName":"Unknown","longName":"4266671","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C00C1A-0A55-5623-E040-BB89AD4375BC","latestVersionIndicator":"Yes","beginDate":"2014-04-11","endDate":null,"createdBy":"DWARZEL","dateCreated":"2014-04-11","modifiedBy":"COLBERTM","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696D344-DF8A-12BB-E053-731AD00A7028","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696F3C3-874A-173B-E053-731AD00A26AA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","deletedIndicator":"No"},{"value":"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas","valueDescription":null,"ValueMeaning":{"publicId":"13162655","version":"1","preferredName":"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas","longName":"13162655v1.00","preferredDefinition":"Progressive, symptomatic neurofibromatosis type 1 associated with plexiform neurofibromas that cannot be removed surgically without risk of substantial morbidity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas","conceptCode":"C143014","definition":"Progressive, symptomatic neurofibromatosis type 1 associated with plexiform neurofibromas that cannot be removed surgically without risk of substantial morbidity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F696F3C3-8749-173B-E053-731AD00A26AA","latestVersionIndicator":"Yes","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F696F3C3-874E-173B-E053-731AD00A26AA","beginDate":"2023-03-10","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-03-10","modifiedBy":"FINCHAMB","dateModified":"2023-03-14","deletedIndicator":"No"},{"value":"13q Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"13567116","version":"1","preferredName":"Monosomy 13q Syndrome","longName":"13567116v1.00","preferredDefinition":"A rare syndrome that is characterized by the partial deletion of the long arm of chromosome 13. Signs and symptoms include low birth weight, craniofacial malformations, hands and feet malformations, and mental and psychomotor retardation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monosomy 13q Syndrome","conceptCode":"C98993","definition":"A rare syndrome that is characterized by the partial deletion of the long arm of chromosome 13. Signs and symptoms include low birth weight, craniofacial malformations, hands and feet malformations, and mental and psychomotor retardation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB6F6D69-F912-7D88-E053-731AD00A77B6","latestVersionIndicator":"Yes","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F913-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Melanoma","valueDescription":null,"ValueMeaning":{"publicId":"5581342","version":"1","preferredName":"Melanoma","longName":"5581342","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F914-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Osteoscarcoma","valueDescription":null,"ValueMeaning":{"publicId":"5207491","version":"1","preferredName":"Stratum 3: Osteosarcoma patients","longName":"5207491","preferredDefinition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteosarcoma","conceptCode":"C9145","definition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F599C02-BE31-4D24-E050-BB89AD436193","latestVersionIndicator":"Yes","beginDate":"2016-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F915-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Liposarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3179354","version":"1","preferredName":"Liposarcoma","longName":"3179354","preferredDefinition":"A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Representative morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid/round cell liposarcoma.  The metastatic potential is higher in less differentiated tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liposarcoma","conceptCode":"C3194","definition":"A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid liposarcoma.  The metastatic potential is higher in less differentiated tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-84F7-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F916-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Breast Cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581329","version":"1","preferredName":"Breast Carcinoma","longName":"5581329","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F917-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Lung Cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581336","version":"1","preferredName":"Lung Carcinoma","longName":"5581336","preferredDefinition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F918-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Bladder Cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581326","version":"1","preferredName":"Bladder Carcinoma","longName":"5581326","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B667-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F919-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"4265253","version":"1","preferredName":"Rhabdomyosarcoma","longName":"4265253","preferredDefinition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyosarcoma","conceptCode":"C3359","definition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4BB4-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F91A-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Thyroid Cancer","valueDescription":null,"ValueMeaning":{"publicId":"5581344","version":"1","preferredName":"Thyroid Gland Carcinoma","longName":"5581344","preferredDefinition":"A carcinoma arising from the thyroid gland. It is usually an adenocarcinoma and includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8E8-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F91B-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"Soft Tissue Sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3384698","version":"1","preferredName":"Soft Tissue Sarcoma","longName":"3384698","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A3DDB0-75C8-1600-E040-BB89AD432CFF","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB6F6D69-F91C-7D88-E053-731AD00A77B6","beginDate":"2023-05-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-11","modifiedBy":"SOKKERL","dateModified":"2023-05-11","deletedIndicator":"No"},{"value":"RB Transcriptional Corepressor 1","valueDescription":null,"ValueMeaning":{"publicId":"3310786","version":"1","preferredName":"RB1 Gene","longName":"3310786","preferredDefinition":"This gene is involved in the regulation of cell differentiation, growth and proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RB1 Gene","conceptCode":"C17360","definition":"This gene is involved in the regulation of cell differentiation, growth and proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2E03D93-A013-407B-E040-BB89AD4306B1","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-11-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD9EDDB1-C7AA-3794-E053-731AD00A3C35","beginDate":"2023-06-08","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-06-08","modifiedBy":"COLBERTM","dateModified":"2023-06-08","deletedIndicator":"No"},{"value":"Ataxia Telangiectasia Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2593388","version":"1","preferredName":"Ataxia Telangiectasia Syndrome","longName":"2593388","preferredDefinition":"Rare hereditary disease characterized by extreme sensitivity to ionizing radiation or radiomimetic drugs because of a defect in DNA repair. AT heterozygosity is estimated to occur in more than 2% of the U.S. population; heterozygotes exhibit increased radiation sensitivity and are at increased risk for several types of cancer. The normal version of the gene that is defective in AT appears to activate the p53-dependent response to DNA damage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ataxia Telangiectasia Syndrome","conceptCode":"C2887","definition":"Rare hereditary disease characterized by extreme sensitivity to ionizing radiation or radiomimetic drugs because of a defect in DNA repair. AT heterozygosity is estimated to occur in more than 2% of the U.S. population; heterozygotes exhibit increased radiation sensitivity and are at increased risk for several types of cancer. The normal version of the gene that is defective in AT appears to activate the p53-dependent response to DNA damage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2883B655-AF9E-439B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A36-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Ataxia-Pancytopenia Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667001","version":"1","preferredName":"Ataxia-Pancytopenia Syndrome","longName":"14667001v1.00","preferredDefinition":"An inherited condition caused by autosomal dominant mutation(s) in the SAMD9L gene, encoding sterile alpha motif domain-containing protein 9-like. The condition is characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to bone marrow failure and myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ataxia-Pancytopenia Syndrome","conceptCode":"C176909","definition":"An inherited condition caused by autosomal dominant mutation(s) in the SAMD9L gene, encoding sterile alpha motif domain-containing protein 9-like. The condition is characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to bone marrow failure and myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A1B-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A37-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Attenuated Familial Adenomatous Polyposis","valueDescription":null,"ValueMeaning":{"publicId":"14667002","version":"1","preferredName":"Attenuated Familial Adenomatous Polyposis","longName":"14667002v1.00","preferredDefinition":"A rare genetic syndrome with an autosomal dominant pattern of inheritance. It was formerly called hereditary flat adenoma syndrome (HFAS) but is now recognized as an attenuated variant of familial adenomatous polyposis (FAP). It is most commonly associated with mutations in the APC gene specifically: exons 1-5, exon 9 and in the distal 3' terminus. Clinical presentation occurs in the middle decades and is characterized by the proximal development of multiple (but less than 100), non-polypoid colonic adenomas. Clinical progression to colorectal cancer may occur later in life but the risk is less than with classic FAP.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Attenuated Familial Adenomatous Polyposis","conceptCode":"C6729","definition":"A rare genetic syndrome with an autosomal dominant pattern of inheritance. It was formerly called hereditary flat adenoma syndrome (HFAS) but is now recognized as an attenuated variant of familial adenomatous polyposis (FAP). It is most commonly associated with mutations in the APC gene specifically: exons 1-5, exon 9 and in the distal 3' terminus. Clinical presentation occurs in the middle decades and is characterized by the proximal development of multiple (but less than 100), non-polypoid colonic adenomas. Clinical progression to colorectal cancer may occur later in life but the risk is less than with classic FAP.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A1C-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A38-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Autism Spectrum Disorder","valueDescription":null,"ValueMeaning":{"publicId":"3165570","version":"1","preferredName":"Autism Spectrum Disorder","longName":"3165570","preferredDefinition":"A spectrum of developmental disorders that includes autism, Asperger syndrome, and Rett syndrome.  Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autism Spectrum Disorder","conceptCode":"C88412","definition":"A spectrum of developmental disorders that includes autism, Asperger syndrome, and Rett syndrome. Signs and symptoms include poor communication skills, defective social interactions, and repetitive behaviors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C1D7-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A39-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"BAP1 Tumor Predisposition Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"7465915","version":"1","preferredName":"BAP1 Tumor Predisposition Syndrome","longName":"7465915","preferredDefinition":"A syndrome caused by germline mutations in the BAP1 gene. It is inherited in an autosomal dominant pattern. Individuals carrying heterozygous BAP1 mutations have an increased risk of developing various tumor types, most commonly BAP1-inactivated nevi /melanocytomas of the skin, uveal and cutaneous melanomas, peritoneal and pleural mesotheliomas, clear cell renal cell carcinoma, and basal cell carcinoma. (WHO 2018)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BAP1 Tumor Predisposition Syndrome","conceptCode":"C172639","definition":"A syndrome caused by germline mutations in the BAP1 gene. It is inherited in an autosomal dominant pattern. Individuals carrying heterozygous BAP1 mutations have an increased risk of developing various tumor types, most commonly BAP1-inactivated nevi /melanocytomas of the skin, uveal and cutaneous melanomas, peritoneal and pleural mesotheliomas, clear cell renal cell carcinoma, and basal cell carcinoma. (WHO 2018)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B89649-8AD0-25AF-E053-4EBD850AB1DC","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A3A-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Birt-Hogg-Dube Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"6789681","version":"1","preferredName":"Birt-Hogg-Dube Syndrome","longName":"6789681","preferredDefinition":"A rare genetic syndrome with an autosomal dominant pattern of inheritance. It is caused by a mutation in the FLCN gene which encodes the protein folliculin. Clinical signs include multiple benign growths of the skin and lungs that begin to manifest in the second or third decade of life. The clinical course is characterized by the progressive growth of new and existing neoplasms. In those with mutations in both copies of FLCN, the kidneys may also be affected by the growth of benign or malignant neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Birt-Hogg-Dube Syndrome","conceptCode":"C28244","definition":"A rare genetic syndrome with an autosomal dominant pattern of inheritance. It is caused by a mutation in the FLCN gene which encodes the protein folliculin. Clinical signs include multiple benign growths of the skin and lungs that begin to manifest in the second or third decade of life. The clinical course is characterized by the progressive growth of new and existing neoplasms. In those with mutations in both copies of FLCN, the kidneys may also be affected by the growth of benign or malignant neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C154154-5023-48BD-E053-F662850A2BF9","latestVersionIndicator":"Yes","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A3B-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Bohring-Opitz Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667003","version":"1","preferredName":"Bohring-Opitz Syndrome","longName":"14667003v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the ASXL1 gene, encoding putative polycomb group protein ASXL1. It is characterized by severe intrauterine growth retardation, profound mental retardation, craniofacial dysmorphisms, and flexion deformities of the upper limbs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bohring-Opitz Syndrome","conceptCode":"C131533","definition":"An autosomal dominant condition caused by mutation(s) in the ASXL1 gene, encoding putative polycomb group protein ASXL1. It is characterized by severe intrauterine growth retardation, profound mental retardation, craniofacial dysmorphisms, and flexion deformities of the upper limbs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A1D-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A3C-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Carney Complex","valueDescription":null,"ValueMeaning":{"publicId":"3210934","version":"1","preferredName":"Carney Syndrome","longName":"3210934","preferredDefinition":"An autosomal dominant disorder most often caused by mutations in the PRKAR1A gene. It is characterized by the presence of myxomas in the heart and skin, skin hyperpigmentation, increased endocrine activity and schwannomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carney Complex","conceptCode":"C4705","definition":"An autosomal dominant disorder most often caused by mutations in the PRKAR1A gene. It is characterized by the presence of myxomas in the heart and skin, skin hyperpigmentation, increased endocrine activity and melanotic schwannomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B6A0-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A3D-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"CDC73-Related Neoplastic Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667004","version":"1","preferredName":"CDC73-Related Neoplastic Syndrome","longName":"14667004v1.00","preferredDefinition":"A group of autosomal dominant-inherited disorders caused by mutation(s) in the CDC73 gene, encoding parafibromin. These disorders are associated with hyperparathyroidism secondary to parathyroid neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDC73-Related Neoplastic Syndrome","conceptCode":"C178382","definition":"A group of autosomal dominant-inherited disorders caused by mutation(s) in the CDC73 gene, encoding parafibromin. These disorders are associated with hyperparathyroidism secondary to parathyroid neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A1E-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A3E-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"CDH1-Associated Breast Carcinoma Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667005","version":"1","preferredName":"CDH1-Associated Breast Carcinoma Syndrome","longName":"14667005v1.00","preferredDefinition":"A cancer susceptibility syndrome caused by inactivating germline mutations of the CDH1 gene. It is associated with the development of lobular carcinoma of the breast. Females with mutation of the CDH1 gene have a 40% risk of developing lobular breast carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDH1-Associated Breast Carcinoma Syndrome","conceptCode":"C176628","definition":"A cancer susceptibility syndrome caused by inactivating germline mutations of the CDH1 gene. It is associated with the development of lobular carcinoma of the breast. Females with mutation of the CDH1 gene have a 40% risk of developing lobular breast carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A1F-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A3F-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Congenital Amegakaryocytic Thrombocytopenia","valueDescription":null,"ValueMeaning":{"publicId":"7351932","version":"1","preferredName":"Congenital Amegakaryocytic Thrombocytopenia","longName":"7351932","preferredDefinition":"A rare, autosomal recessive inherited disorder caused by mutation in the c-Mpl gene.  It is characterized by thrombocytopenia and absence of megakaryocytes.  It presents with bleeding in the first month of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Amegakaryocytic Thrombocytopenia","conceptCode":"C115207","definition":"A rare, autosomal recessive inherited disorder caused by mutation in the c-Mpl gene.  It is characterized by thrombocytopenia and absence of megakaryocytes.  It presents with bleeding in the first month of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA67492F-5012-3409-E053-4EBD850AE5D7","latestVersionIndicator":"Yes","beginDate":"2020-07-14","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-14","modifiedBy":"ONEDATA","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A40-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Dyskeratosis Congenita","valueDescription":null,"ValueMeaning":{"publicId":"3940911","version":"1","preferredName":"Dyskeratosis Congenita","longName":"3940911","preferredDefinition":"A rare genetic disorder characterized by nail dystrophy, reticulated skin pigmentation especially on the neck and chest, and oral leukoplakia.  In about half the cases mutations in the TERT, TERC, DKC1, or TINF2 genes are identified.  Patients are at an increased risk of developing bone marrow failure, myelodysplastic syndrome, leukemia, or cancer, especially in the head and neck region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyskeratosis Congenita","conceptCode":"C111802","definition":"A rare genetic disorder characterized by nail dystrophy, reticulated skin pigmentation especially on the neck and chest, and oral leukoplakia.  In about half the cases mutations in the TERT, TERC, DKC1, or TINF2 genes are identified.  Patients are at an increased risk of developing bone marrow failure, myelodysplastic syndrome, leukemia, or cancer, especially in the head and neck region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA08B251-5C80-ED4B-E040-BB89AD4371A4","latestVersionIndicator":"Yes","beginDate":"2013-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A41-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Familial Adenomatous Polyposis","valueDescription":null,"ValueMeaning":{"publicId":"2577526","version":"1","preferredName":"Adenomatous Polyposis Coli","longName":"2577526","preferredDefinition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Familial Adenomatous Polyposis","conceptCode":"C3339","definition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"COOPERM","dateModified":"2018-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A42-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"GATA2 Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5207249","version":"1","preferredName":"GATA2 Deficiency","longName":"5207249","preferredDefinition":"A condition of decreased or absent presence or activity of endothelial transcription factor GATA-2 protein. Deficiency of this protein is associated with immunodeficiency 21 and autosomal dominant and sporadic monocytopenia and mycobacterial infection syndrome (MonoMAC).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GATA2 Deficiency","conceptCode":"C126349","definition":"A condition of decreased or absent presence or activity of endothelial transcription factor GATA-2 protein. Deficiency of this protein is associated with immunodeficiency 21 and autosomal dominant and sporadic monocytopenia and mycobacterial infection syndrome (MonoMAC).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4512-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A43-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Genetic Predisposition to Melanoma","valueDescription":null,"ValueMeaning":{"publicId":"14667006","version":"1","preferredName":"Genetic Predisposition to Melanoma","longName":"14667006v1.00","preferredDefinition":"An inherited condition caused by mutation(s) in the CDKN2A or CDK4 genes, encoding cyclin-dependent kinase inhibitor 2A and cyclin-dependent kinase 4, respectively. The condition is characterized by an increased risk of developing melanoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Predisposition to Melanoma","conceptCode":"C179472","definition":"An inherited condition caused by mutation(s) in the CDKN2A or CDK4 genes, encoding cyclin-dependent kinase inhibitor 2A and cyclin-dependent kinase 4, respectively. The condition is characterized by an increased risk of developing melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A20-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A44-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Genetic Predisposition to Meningioma","valueDescription":null,"ValueMeaning":{"publicId":"14667007","version":"1","preferredName":"Genetic Predisposition to Meningioma","longName":"14667007v1.00","preferredDefinition":"An inherited condition caused by mutation(s) in the SMARCE1 gene, encoding SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1. The condition is characterized by an increased risk of developing meningioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Predisposition to Meningioma","conceptCode":"C179471","definition":"An inherited condition caused by mutation(s) in the SMARCE1 gene, encoding SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1. The condition is characterized by an increased risk of developing meningioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A21-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A45-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Genetic Predisposition to Myofibromatosis","valueDescription":null,"ValueMeaning":{"publicId":"14667008","version":"1","preferredName":"Genetic Predisposition to Myofibromatosis","longName":"14667008v1.00","preferredDefinition":"An inherited condition caused by mutation(s) in the NOTCH3 or PDGFRB genes, encoding neurogenic locus notch homolog protein 3 and platelet-derived growth factor receptor beta, respectively. The condition is characterized by an increased risk of developing myofibroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Predisposition to Myofibromatosis","conceptCode":"C179470","definition":"An inherited condition caused by mutation(s) in the NOTCH3 or PDGFRB genes, encoding neurogenic locus notch homolog protein 3 and platelet-derived growth factor receptor beta, respectively. The condition is characterized by an increased risk of developing myofibroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A22-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A46-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Genetic Predisposition to Neuroblastoma","valueDescription":null,"ValueMeaning":{"publicId":"14667009","version":"1","preferredName":"Genetic Predisposition to Neuroblastoma","longName":"14667009v1.00","preferredDefinition":"An inherited condition caused by mutation(s) in the ALK or PHOX2B genes, encoding ALK tyrosine kinase receptor and paired mesoderm homeobox protein 2B, respectively. The condition is characterized by an increased risk of developing neuroblastoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Predisposition to Neuroblastoma","conceptCode":"C179469","definition":"An inherited condition caused by mutation(s) in the ALK or PHOX2B genes, encoding ALK tyrosine kinase receptor and paired mesoderm homeobox protein 2B, respectively. The condition is characterized by an increased risk of developing neuroblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A23-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A47-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Genetic Predisposition to Non-Syndromic Wilms Tumor","valueDescription":null,"ValueMeaning":{"publicId":"14667010","version":"1","preferredName":"Genetic Predisposition to Non-Syndromic Wilms Tumor","longName":"14667010v1.00","preferredDefinition":"A genetic predisposition to Wilms tumor due to germline mutation(s) in the REST, TRIM28, or CTR9 genes, encoding RE1-silencing transcription factor, transcription intermediary factor 1-beta, and RNA polymerase-associated protein CTR9 homolog, respectively.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Predisposition to Non-Syndromic Wilms Tumor","conceptCode":"C178392","definition":"A genetic predisposition to Wilms tumor due to germline mutation(s) in the REST, TRIM28, or CTR9 genes, encoding RE1-silencing transcription factor, transcription intermediary factor 1-beta, and RNA polymerase-associated protein CTR9 homolog, respectively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A24-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A48-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Genetic Predisposition to Papillary Renal Cell Carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"14667011","version":"1","preferredName":"Genetic Predisposition to Papillary Renal Cell Carcinoma","longName":"14667011v1.00","preferredDefinition":"An inherited condition caused by mutation(s) in the MET gene, encoding hepatocyte growth factor receptor. The condition is characterized by an increased risk of developing papillary renal cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Predisposition to Papillary Renal Cell Carcinoma","conceptCode":"C179473","definition":"An inherited condition caused by mutation(s) in the MET gene, encoding hepatocyte growth factor receptor. The condition is characterized by an increased risk of developing papillary renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A25-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A49-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Hepatolenticular Degeneration","valueDescription":null,"ValueMeaning":{"publicId":"3211134","version":"1","preferredName":"Hepatolenticular Degeneration","longName":"3211134","preferredDefinition":"A rare autosomal recessive inherited disorder caused by mutations in the ATP7B gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatolenticular Degeneration","conceptCode":"C84756","definition":"A rare autosomal recessive inherited disorder caused by mutations in the ATP7B gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D2B2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A4A-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Juvenile Polyposis Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667012","version":"1","preferredName":"Juvenile Polyposis Syndrome","longName":"14667012v1.00","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome. Mutations in the SMAD4 or BMPR1A genes have been identified in some patients. It is characterized by the presence of multiple juvenile polyps in the gastrointestinal tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juvenile Polyposis Syndrome","conceptCode":"C7754","definition":"An autosomal dominant hereditary neoplastic syndrome. Mutations in the SMAD4 or BMPR1A genes have been identified in some patients. It is characterized by the presence of multiple juvenile polyps in the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A26-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A4B-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Legius Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667013","version":"1","preferredName":"Legius Syndrome","longName":"14667013v1.00","preferredDefinition":"An inherited condition caused by autosomal dominant mutation(s) in the SPRED1 gene, encoding sprouty-related, EVH1 domain-containing protein 1. The condition resembles neurofibromatosis type I but is less severe. Affected individuals may present with multiple cafe-au-lait spots, variable dysmorphic features, including hypertelorism or macrocephaly, lipomas, and mild learning disabilities or attention problems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Legius Syndrome","conceptCode":"C176941","definition":"An inherited condition caused by autosomal dominant mutation(s) in the SPRED1 gene, encoding sprouty-related, EVH1 domain-containing protein 1. The condition resembles neurofibromatosis type I but is less severe. Affected individuals may present with multiple cafe-au-lait spots, variable dysmorphic features, including hypertelorism or macrocephaly, lipomas, and mild learning disabilities or attention problems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A27-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A4C-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"LEOPARD Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211219","version":"1","preferredName":"LEOPARD Syndrome","longName":"3211219","preferredDefinition":"A genetic syndrome caused by mutations in the PTPN11 and RAF1 genes. It is characterized by the following abnormalities: multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities in genitalia, growth retardation, and deafness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LEOPARD Syndrome","conceptCode":"C84820","definition":"A genetic syndrome caused by mutations in the PTPN11 and RAF1 genes. It is characterized by the following abnormalities: multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities in genitalia, growth retardation, and deafness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DE95-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A4D-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"MIRAGE Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667014","version":"1","preferredName":"MIRAGE Syndrome","longName":"14667014v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the SAMD9 gene, encoding sterile alpha motif domain-containing protein 9A. It is a syndromic condition comprising myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital abnormalities, and enteropathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MIRAGE Syndrome","conceptCode":"C147530","definition":"An autosomal dominant condition caused by mutation(s) in the SAMD9 gene, encoding sterile alpha motif domain-containing protein 9A. It is a syndromic condition comprising myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital abnormalities, and enteropathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A28-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A4E-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Mosaic Variegated Aneuploidy Syndrome 1","valueDescription":null,"ValueMeaning":{"publicId":"14667015","version":"1","preferredName":"Mosaic Variegated Aneuploidy Syndrome 1","longName":"14667015v1.00","preferredDefinition":"An autosomal recessive genetic disorder caused by mutation(s) in the BUB1B gene, encoding mitotic checkpoint serine/threonine-protein kinase B. The condition is characterized by a predisposition to mitotic non-disjunction, resulting in a high percentage of aneuploid cells. The phenotype is variable and there is a predisposition to cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mosaic Variegated Aneuploidy Syndrome 1","conceptCode":"C128192","definition":"An autosomal recessive genetic disorder caused by mutation(s) in the BUB1B gene, encoding mitotic checkpoint serine/threonine-protein kinase B. The condition is characterized by a predisposition to mitotic non-disjunction, resulting in a high percentage of aneuploid cells. The phenotype is variable and there is a predisposition to cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A29-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A4F-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Mulibrey Nanism","valueDescription":null,"ValueMeaning":{"publicId":"3211266","version":"1","preferredName":"Mulibrey Nanism","longName":"3211266","preferredDefinition":"An autosomal recessive inherited disorder caused by mutations in the TRIM37 gene. It is characterized by marked growth retardation and abnormalities in multiple organs including heart, liver, muscle, eyes, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mulibrey Nanism","conceptCode":"C84906","definition":"An autosomal recessive inherited disorder caused by mutations in the TRIM37 gene. It is characterized by marked growth retardation and abnormalities in multiple organs including heart, liver, muscle, eyes, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E5B3-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A50-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Multiple Endocrine Neoplasia Type 1","valueDescription":null,"ValueMeaning":{"publicId":"3211270","version":"1","preferredName":"Multiple Endocrine Neoplasia Type 1","longName":"3211270","preferredDefinition":"Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Endocrine Neoplasia Type 1","conceptCode":"C3225","definition":"Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-E63B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A51-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Multiple Endocrine Neoplasia Type 2","valueDescription":null,"ValueMeaning":{"publicId":"14667016","version":"1","preferredName":"Multiple Endocrine Neoplasia Type 2","longName":"14667016v1.00","preferredDefinition":"Multiple endocrine neoplasia caused by mutation of the RET gene. It includes the following neoplastic processes: multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and hereditary thyroid gland medullary carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Endocrine Neoplasia Type 2","conceptCode":"C123329","definition":"Multiple endocrine neoplasia caused by mutation of the RET gene. It includes the following neoplastic processes: multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and hereditary thyroid gland medullary carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A2A-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A52-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Multiple Endocrine Neoplasia Type 4","valueDescription":null,"ValueMeaning":{"publicId":"14667017","version":"1","preferredName":"Multiple Endocrine Neoplasia Type 4","longName":"14667017v1.00","preferredDefinition":"An autosomal dominant tumor syndrome caused by germline CDKN1B mutations that result in a phenotype similar to that of multiple endocrine neoplasia type 1, characterized by endocrine neoplasms, particularly in the parathyroid glands, pituitary, and pancreas. (WHO 2017)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Endocrine Neoplasia Type 4","conceptCode":"C157449","definition":"An autosomal dominant tumor syndrome caused by germline CDKN1B mutations that result in a phenotype similar to that of multiple endocrine neoplasia type 1, characterized by endocrine neoplasms, particularly in the parathyroid glands, pituitary, and pancreas. (WHO 2017)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A2B-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A53-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"MUTYH-Associated Polyposis","valueDescription":null,"ValueMeaning":{"publicId":"14667018","version":"1","preferredName":"MUTYH-Associated Polyposis","longName":"14667018v1.00","preferredDefinition":"An autosomal recessive hereditary neoplastic syndrome caused by mutations in the MUTYH gene on chromosome 1p34.1.  It is characterized by the presence of multiple colorectal polyps that may progress to carcinoma.  Development of gastric and small intestinal polyps may also occur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MUTYH-Associated Polyposis","conceptCode":"C96520","definition":"An autosomal recessive hereditary neoplastic syndrome caused by mutations in the MUTYH gene on chromosome 1p34.1.  It is characterized by the presence of multiple colorectal polyps that may progress to carcinoma.  Development of gastric and small intestinal polyps may also occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A2C-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A54-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Nevoid Basal Cell Carcinoma Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3210902","version":"1","preferredName":"Nevoid Basal Cell Carcinoma Syndrome","longName":"3210902","preferredDefinition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH gene.  It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida).  Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nevoid Basal Cell Carcinoma Syndrome","conceptCode":"C2892","definition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH and SUFU gene. It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida). Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B1D8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A55-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Nijmegen Breakage Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211305","version":"1","preferredName":"Nijmegen Breakage Syndrome","longName":"3211305","preferredDefinition":"A disorder, wherein unstable chromosomes have a tendency to break and become rearranged, characterized by microcephaly, stunted growth, subnormal mental development, cafe-au-lait spots, and immunodeficiency. The syndrome is named after the University of Nijmegen in the Netherlands. (JABL99)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nijmegen Breakage Syndrome","conceptCode":"C4692","definition":"A disorder, wherein unstable chromosomes have a tendency to break and become rearranged, characterized by microcephaly, stunted growth, subnormal mental development, cafe-au-lait spots, and immunodeficiency. The syndrome is named after the University of Nijmegen in the Netherlands. (JABL99)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EB5B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A56-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Noonan Syndrome-Like Disorder with Loose Anagen Hair","valueDescription":null,"ValueMeaning":{"publicId":"14667019","version":"1","preferredName":"Noonan Syndrome-Like Disorder with Loose Anagen Hair","longName":"14667019v1.00","preferredDefinition":"An inherited condition caused by autosomal dominant mutation(s) in the SHOC2 or PPP1CB genes, encoding leucine-rich repeat protein SHOC-2 and serine/threonine-protein phosphatase PP1-beta catalytic subunit, respectively. The condition is characterized by facial features similar to those seen in Noonan syndrome but may also include short stature, cognitive deficits, relative macrocephaly, small posterior fossa resulting in Chiari I malformation, hypernasal voice, cardiac defects, and ectodermal abnormalities, which typically presents as slow-growing, sparse, and/or unruly hair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Noonan Syndrome-Like Disorder with Loose Anagen Hair","conceptCode":"C178129","definition":"An inherited condition caused by autosomal dominant mutation(s) in the SHOC2 or PPP1CB genes, encoding leucine-rich repeat protein SHOC-2 and serine/threonine-protein phosphatase PP1-beta catalytic subunit, respectively. The condition is characterized by facial features similar to those seen in Noonan syndrome but may also include short stature, cognitive deficits, relative macrocephaly, small posterior fossa resulting in Chiari I malformation, hypernasal voice, cardiac defects, and ectodermal abnormalities, which typically presents as slow-growing, sparse, and/or unruly hair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A2D-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A57-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Oculocutaneous Albinism","valueDescription":null,"ValueMeaning":{"publicId":"3211312","version":"1","preferredName":"Oculocutaneous Albinism","longName":"3211312","preferredDefinition":"An autosomal recessive inherited disorder caused by mutations of the OCA2, SLC45A2, TYR and TYRP1 genes. It is characterized by hypopigmentation of the skin, hair, and eyes, resulting in very fair skin, white colored hair, and reduced pigmentation in the iris and retina. Individuals may have vision disturbances and photophobia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oculocutaneous Albinism","conceptCode":"C84941","definition":"An autosomal recessive inherited disorder caused by mutations of the OCA2, SLC45A2, TYR and TYRP1 genes. It is characterized by hypopigmentation of the skin, hair, and eyes, resulting in very fair skin, white colored hair, and reduced pigmentation in the iris and retina. Individuals may have vision disturbances and photophobia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EC5B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A58-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Perlman Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667020","version":"1","preferredName":"Perlman Syndrome","longName":"14667020v1.00","preferredDefinition":"A rare, autosomal recessive syndrome characterized by the presence of polyhydramnios, neonatal macrosomia, craniofacial abnormalities, nephroblastomatosis, and predisposition to Wilms tumor.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perlman Syndrome","conceptCode":"C103144","definition":"A rare, autosomal recessive syndrome characterized by the presence of polyhydramnios, neonatal macrosomia, craniofacial abnormalities, nephroblastomatosis, and predisposition to Wilms tumor.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A2E-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A59-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"PIK3CA-Related Overgrowth Spectrum","valueDescription":null,"ValueMeaning":{"publicId":"14667021","version":"1","preferredName":"PIK3CA-Related Overgrowth Spectrum","longName":"14667021v1.00","preferredDefinition":"A group of rare disorders that are usually caused by somatic mutations in the PIK3CA gene, but may rarely be caused by de novo germline mutations. These disorders are typically characterized by sporadic overgrowth of parts of the body, intellectual disability, low muscle tone, and vascular malformations with congenital or early childhood onset. Representative examples include: fibroadipose hyperplasia, CLOVES syndrome, megalencephaly-capillary malformation syndrome, hemihyperplasia-multiple lipomatosis syndrome, hemimegalencephaly, and facial infiltrating lipomatosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PIK3CA-Related Overgrowth Spectrum","conceptCode":"C178285","definition":"A group of rare disorders that are usually caused by somatic mutations in the PIK3CA gene, but may rarely be caused by de novo germline mutations. These disorders are typically characterized by sporadic overgrowth of parts of the body, intellectual disability, low muscle tone, and vascular malformations with congenital or early childhood onset. Representative examples include: fibroadipose hyperplasia, CLOVES syndrome, megalencephaly-capillary malformation syndrome, hemihyperplasia-multiple lipomatosis syndrome, hemimegalencephaly, and facial infiltrating lipomatosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A2F-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A5A-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Radial Aplasia-Thrombocytopenia Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667022","version":"1","preferredName":"Radial Aplasia-Thrombocytopenia Syndrome","longName":"14667022v1.00","preferredDefinition":"A rare syndrome characterized by the presence of thrombocytopenia associated with bilateral absence of the radius bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radial Aplasia-Thrombocytopenia Syndrome","conceptCode":"C99038","definition":"A rare syndrome characterized by the presence of thrombocytopenia associated with bilateral absence of the radius bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A30-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A5B-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Rhabdoid Tumor Predisposition Syndrome 1","valueDescription":null,"ValueMeaning":{"publicId":"14667023","version":"1","preferredName":"Rhabdoid Tumor Predisposition Syndrome 1","longName":"14667023v1.00","preferredDefinition":"Rhabdoid tumor predisposition syndrome caused by mutation(s) in the SMARCB1 gene, encoding SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdoid Tumor Predisposition Syndrome 1","conceptCode":"C178393","definition":"Rhabdoid tumor predisposition syndrome caused by mutation(s) in the SMARCB1 gene, encoding SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A31-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A5C-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Rhabdoid Tumor Predisposition Syndrome 2","valueDescription":null,"ValueMeaning":{"publicId":"14667024","version":"1","preferredName":"Rhabdoid Tumor Predisposition Syndrome 2","longName":"14667024v1.00","preferredDefinition":"Rhabdoid tumor predisposition syndrome caused by mutation(s) in the SMARCA4 gene, encoding transcription activator BRG1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdoid Tumor Predisposition Syndrome 2","conceptCode":"C178394","definition":"Rhabdoid tumor predisposition syndrome caused by mutation(s) in the SMARCA4 gene, encoding transcription activator BRG1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A32-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A5D-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Rubinstein-Taybi Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211427","version":"1","preferredName":"Rubinstein-Taybi Syndrome","longName":"3211427","preferredDefinition":"A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene.  It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes.  Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rubinstein-Taybi Syndrome","conceptCode":"C75466","definition":"A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene. It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes. Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FC39-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A5E-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Schwannomatosis","valueDescription":null,"ValueMeaning":{"publicId":"6832486","version":"1","preferredName":"Schwannomatosis","longName":"6832486","preferredDefinition":"A rare genetic disorder characterized by the presence of multiple schwannomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schwannomatosis","conceptCode":"C6557","definition":"Rare genetic disorder caused by mutations in the SMARCB1 and LZTR1 genes. It is characterized by the presence of multiple Schwannomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9A76BA-99B0-69B5-E053-F662850AA843","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A5F-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Shwachman-Diamond Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"5651021","version":"1","preferredName":"Shwachman-Diamond Syndrome","longName":"5651021","preferredDefinition":"A rare, autosomal recessive disorder characterized by exocrine pancreas insufficiency, skeletal abnormalities, bone marrow dysfunction, and an increased incidence of leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shwachman-Diamond Syndrome","conceptCode":"C61235","definition":"A rare, autosomal recessive disorder characterized by exocrine pancreas insufficiency, skeletal abnormalities, bone marrow dysfunction, and an increased incidence of leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"479020AD-0C96-3909-E053-F662850A62CA","latestVersionIndicator":"Yes","beginDate":"2017-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A60-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Simpson-Golabi-Behmel Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667025","version":"1","preferredName":"Simpson-Golabi-Behmel Syndrome","longName":"14667025v1.00","preferredDefinition":"An X-linked recessive syndrome caused by mutation(s) in the GPC3, OFD1, or rarely the GPC4 gene, encoding glypican 3, oral-facial-digital syndrome 1 protein, and glypican 4, respectively. The condition is characterized by macrosomia, coarse facies, cryptorchidism, congenital heart, kidney, liver, spleen, and musculoskeletal abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Simpson-Golabi-Behmel Syndrome","conceptCode":"C131002","definition":"An X-linked recessive syndrome caused by mutation(s) in the GPC3, OFD1, or rarely the GPC4 gene, encoding glypican 3, oral-facial-digital syndrome 1 protein, and glypican 4, respectively. The condition is characterized by macrosomia, coarse facies, cryptorchidism, congenital heart, kidney, liver, spleen, and musculoskeletal abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A33-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A61-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Tuberous Sclerosis","valueDescription":null,"ValueMeaning":{"publicId":"2962075","version":"1","preferredName":"Tuberous Sclerosis","longName":"2962075","preferredDefinition":"Hereditary disease characterized by seizures, mental retardation, developmental delay, and skin and ocular lesions. First signs usually occur during infancy or childhood but in rare cases may not occur until 2nd or 3rd decade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tuberous Sclerosis","conceptCode":"C3424","definition":"Hereditary disease characterized by seizures, mental retardation, developmental delay, and skin and ocular lesions. First signs usually occur during infancy or childhood but in rare cases may not occur until 2nd or 3rd decade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A1B-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A62-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Tyrosinemia Type I","valueDescription":null,"ValueMeaning":{"publicId":"14667026","version":"1","preferredName":"Tyrosinemia Type I","longName":"14667026v1.00","preferredDefinition":"Tyrosinemia caused by mutations in the FAH gene. It is characterized by deficiency of the enzyme fumarylacetoacetate hydrolase. It is the most severe form of tyrosinemia. Signs and symptoms appear early in life and include failure to thrive, vomiting, diarrhea, jaundice, and bleeding tendency. It may result in liver and kidney failure. Patients with this type of tyrosinemia may also have a predisposition for hepatocellular carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tyrosinemia Type I","conceptCode":"C98641","definition":"Tyrosinemia caused by mutations in the FAH gene. It is characterized by deficiency of the enzyme fumarylacetoacetate hydrolase. It is the most severe form of tyrosinemia. Signs and symptoms appear early in life and include failure to thrive, vomiting, diarrhea, jaundice, and bleeding tendency. It may result in liver and kidney failure. Patients with this type of tyrosinemia may also have a predisposition for hepatocellular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A34-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A63-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Von Hippel-Lindau Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2962084","version":"1","preferredName":"Von Hippel-Lindau Syndrome","longName":"2962084","preferredDefinition":"An inherited familial cancer syndrome which is characterized by development of capillary hemangioblastomas of the central nervous system and retina; clear cell renal carcinoma; pheochromocytoma; pancreatic tumors; and inner ear tumors. The syndrome is associated with germline mutations of the VHL tumor suppressor gene, located on chromosome 3p25-26. Symptoms of VHL syndrome may not be apparent until the third decade of life. CNS hemangioblastoma is the most common cause of death, followed by clear cell renal cell carcinoma. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Von Hippel Lindau Syndrome","conceptCode":"C3105","definition":"An inherited familial cancer syndrome which is characterized by development of capillary hemangioblastomas of the central nervous system and retina; clear cell renal carcinoma; pheochromocytoma; pancreatic tumors; and inner ear tumors. The syndrome is associated with germline mutations of the VHL tumor suppressor gene, located on chromosome 3p25-26. Symptoms of VHL syndrome may not be apparent until the third decade of life. CNS hemangioblastoma is the most common cause of death, followed by clear cell renal cell carcinoma. --2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4AD9-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A64-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Weaver Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14667027","version":"1","preferredName":"Weaver Syndrome","longName":"14667027v1.00","preferredDefinition":"A rare syndrome caused by mutations in the EZH2 gene, and rarely mutations in the NSD1 gene. It is characterized by advanced bone age, foot deformities, permanently bent joints, macrocephaly, flattened back of the head, a broad forehead, hypertelorism, large, low-set ears, micrognathia, delayed development of motor skills, and mild intellectual disability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weaver Syndrome","conceptCode":"C125599","definition":"A rare syndrome caused by mutations in the EZH2 gene, and rarely mutations in the NSD1 gene. It is characterized by advanced bone age, foot deformities, permanently bent joints, macrocephaly, flattened back of the head, a broad forehead, hypertelorism, large, low-set ears, micrognathia, delayed development of motor skills, and mild intellectual disability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D843833-3A35-3582-E063-731AD00A2CDC","latestVersionIndicator":"Yes","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A65-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"X-linked Lymphoproliferative Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3326336","version":"1","preferredName":"X-Linked Lymphoproliferative Syndrome","longName":"3326336","preferredDefinition":"An X-linked immunodeficiency syndrome that exclusivesly affects males, although females can be carriers. The syndrome is characterized by life-threatening episodes of infectious mononucleosis, hypogammaglobulinemia, and subsequent development of lymphomas (usually B-cell lymphomas) and other lymphoproliferative disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Linked Lymphoproliferative Syndrome","conceptCode":"C61246","definition":"An X-linked immunodeficiency syndrome that exclusively affects males, although females can be carriers. It is caused by mutation(s) in SH2D1A and/or XIAP genes and is characterized by life-threatening episodes of infectious mononucleosis, hypogammaglobulinemia, and subsequent development of lymphomas (usually B-cell lymphomas) and other lymphoproliferative disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B734-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"ONEDATA","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A66-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Xeroderma Pigmentosum","valueDescription":null,"ValueMeaning":{"publicId":"3211533","version":"1","preferredName":"Xeroderma Pigmentosum","longName":"3211533","preferredDefinition":"An inherited skin disorder characterized by photosensitivity with severe sunburn in infancy, the development of numerous pigmented spots resembling freckles, larger atrophic lesions associated with telangiectasis, and multiple solar keratoses. Transmitted in an autosomal recessive manner, xeroderma pigmentosa involves a defect in nucleotide excision repair (NER), leading to deficient repair of DNA damaged by UV radiation and chromosome breakage. Individuals with this disease develop multiple malignant cutaneous neoplasms at an early age and may suffer from severe ophthalmic and neurologic abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Xeroderma Pigmentosum","conceptCode":"C3452","definition":"An inherited skin disorder characterized by photosensitivity with severe sunburn in infancy, the development of numerous pigmented spots resembling freckles, larger atrophic lesions associated with telangiectasis, and multiple solar keratoses. Transmitted in an autosomal recessive manner, xeroderma pigmentosa involves a defect in nucleotide excision repair (NER), leading to deficient repair of DNA damaged by UV radiation and chromosome breakage. Individuals with this disease develop multiple malignant cutaneous neoplasms at an early age and may suffer from severe ophthalmic and neurologic abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0BED-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D843833-3A67-3582-E063-731AD00A2CDC","beginDate":"2023-12-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-12-27","modifiedBy":"SOKKERL","dateModified":"2023-12-27","deletedIndicator":"No"},{"value":"Acute Lymphoblastic Leukemia Susceptibility - PAX5","valueDescription":null,"ValueMeaning":{"publicId":"14758827","version":"1","preferredName":"Acute Lymphoblastic Leukemia, Susceptibility to, 3","longName":"14758827v1.00","preferredDefinition":"An inherited condition caused by mutation(s) in the PAX5 gene, encoding paired box protein Pax-5. The condition is characterized by an increased risk of developing B-cell acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia, Susceptibility to, 3","conceptCode":"C176907","definition":"An inherited condition caused by mutation(s) in the PAX5 gene, encoding paired box protein Pax-5. The condition is characterized by an increased risk of developing B-cell acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3B9A-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BA8-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"ANKRD26-Related Thrombocytopenia and Leukemia Predisposition","valueDescription":null,"ValueMeaning":{"publicId":"14758828","version":"1","preferredName":"ANKRD26-Related Predisposition to Leukemia and Thrombocytopenia","longName":"14758828v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the ANKRD26 gene, encoding ankyrin repeat domain-containing protein 26. It is characterized by moderate thrombocytopenia and an increased risk of developing myelodysplastic syndrome/acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ANKRD26-Related Predisposition to Leukemia and Thrombocytopenia","conceptCode":"C178387","definition":"An autosomal dominant condition caused by mutation(s) in the ANKRD26 gene, encoding ankyrin repeat domain-containing protein 26. It is characterized by moderate thrombocytopenia and an increased risk of developing myelodysplastic syndrome/acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3B9B-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BA9-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann Syndrome/Isolated Hemihyperplasia","valueDescription":null,"ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BAA-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"CBL Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14758829","version":"1","preferredName":"Noonan Syndrome-Like Disorder with or without Juvenile Myelomonocytic Leukemia","longName":"14758829v1.00","preferredDefinition":"An inherited condition caused by autosomal dominant mutation(s) in the CBL gene, encoding E3 ubiquitin-protein ligase CBL. The condition resembles Noonan syndrome 1 and is characterized by facial dysmorphism, a wide spectrum of cardiac disease, reduced growth, variable cognitive deficits, and ectodermal and musculoskeletal anomalies. Affected individuals may have an increased risk for certain malignancies, particularly juvenile myelomonocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Noonan Syndrome-Like Disorder with or without Juvenile Myelomonocytic Leukemia","conceptCode":"C176942","definition":"An inherited condition caused by autosomal dominant mutation(s) in the CBL gene, encoding E3 ubiquitin-protein ligase CBL. The condition resembles Noonan syndrome 1 and is characterized by facial dysmorphism, a wide spectrum of cardiac disease, reduced growth, variable cognitive deficits, and ectodermal and musculoskeletal anomalies. Affected individuals may have an increased risk for certain malignancies, particularly juvenile myelomonocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3B9C-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BAB-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"CEBPA-Related Leukemia Predisposition","valueDescription":null,"ValueMeaning":{"publicId":"14758830","version":"1","preferredName":"CEPBA-Related Predisposition to Leukemia","longName":"14758830v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the CEBPA gene, encoding CCAAT/enhancer-binding protein alpha. It is characterized by an increased risk of developing hematologic malignancies, primarily myeloid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CEPBA-Related Predisposition to Leukemia","conceptCode":"C178379","definition":"An autosomal dominant condition caused by mutation(s) in the CEBPA gene, encoding CCAAT/enhancer-binding protein alpha. It is characterized by an increased risk of developing hematologic malignancies, primarily myeloid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3B9D-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BAC-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"CHEK2-Associated Cancer Predisposition","valueDescription":null,"ValueMeaning":{"publicId":"14758831","version":"1","preferredName":"CHEK2-Associated Li-Fraumeni-Like Syndrome","longName":"14758831v1.00","preferredDefinition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the CHEK2 gene. It is associated with breast carcinoma, gastric carcinoma, colorectal carcinoma, thyroid gland carcinoma, kidney carcinoma, prostate carcinoma, and non-Hodgkin lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CHEK2-Associated Li-Fraumeni-Like Syndrome","conceptCode":"C176588","definition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the CHEK2 gene. It is associated with breast carcinoma, gastric carcinoma, colorectal carcinoma, thyroid gland carcinoma, kidney carcinoma, prostate carcinoma, and non-Hodgkin lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3B9E-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BAD-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Constitutional Mismatch Repair Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"14758832","version":"1","preferredName":"Constitutional Mismatch Repair Deficiency Syndrome","longName":"14758832v1.00","preferredDefinition":"A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Constitutional Mismatch Repair Deficiency Syndrome","conceptCode":"C130202","definition":"A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3B9F-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BAE-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"DDX41-Related Leukemia Predisposition","valueDescription":null,"ValueMeaning":{"publicId":"14758833","version":"1","preferredName":"DDX41-Related Predisposition to Leukemia","longName":"14758833v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the DDX41 gene, encoding probable ATP-dependent RNA helicase DDX41. It is characterized by an increased risk of developing hematologic malignancies, including myeloid and lymphoid leukemias and lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DDX41-Related Predisposition to Leukemia","conceptCode":"C178380","definition":"An autosomal dominant condition caused by mutation(s) in the DDX41 gene, encoding probable ATP-dependent RNA helicase DDX41. It is characterized by an increased risk of developing hematologic malignancies, including myeloid and lymphoid leukemias and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA0-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BAF-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"ETV6-Related Thrombocytopenia and Leukemia Predisposition","valueDescription":null,"ValueMeaning":{"publicId":"14758834","version":"1","preferredName":"ETV6-Related Predisposition to Leukemia and Thrombocytopenia","longName":"14758834v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the ETV6 gene, encoding transcription factor ETV6. It is characterized by an increased risk of developing thrombocytopenia and diverse hematologic malignancies, including myelodysplastic syndrome, acute myeloid leukemia, chronic myelomonocytic leukemia, B lymphoblastic leukemia, and plasma cell myeloma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ETV6-Related Predisposition to Leukemia and Thrombocytopenia","conceptCode":"C178386","definition":"An autosomal dominant condition caused by mutation(s) in the ETV6 gene, encoding transcription factor ETV6. It is characterized by an increased risk of developing thrombocytopenia and diverse hematologic malignancies, including myelodysplastic syndrome, acute myeloid leukemia, chronic myelomonocytic leukemia, B lymphoblastic leukemia, and plasma cell myeloma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA1-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB0-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Familial Gastrointestinal Stromal Tumor","valueDescription":null,"ValueMeaning":{"publicId":"14758835","version":"1","preferredName":"Hereditary Gastrointestinal Stromal Tumor","longName":"14758835v1.00","preferredDefinition":"An inherited condition caused by autosomal dominant mutation(s) in the KIT or PDGFRA genes, encoding mast/stem cell growth factor receptor Kit and platelet derived growth factor receptor alpha respectively. The condition is characterized by the occurrence of multiple gastrointestinal stromal tumors (GIST).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Gastrointestinal Stromal Tumor","conceptCode":"C176906","definition":"An inherited condition caused by autosomal dominant mutation(s) in the KIT or PDGFRA genes, encoding mast/stem cell growth factor receptor Kit and platelet derived growth factor receptor alpha respectively. The condition is characterized by the occurrence of multiple gastrointestinal stromal tumors (GIST).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA2-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB1-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Familial Paraganglioma-Pheochromocytoma Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14758836","version":"1","preferredName":"Hereditary Paraganglioma-Pheochromocytoma Syndrome","longName":"14758836v1.00","preferredDefinition":"A hereditary cancer syndrome characterized by the development of multiple paragangliomas including pheochromocytomas. It is caused by mutations in SDHA, SDHB, SDHC, SDHD, and SDHAF2 genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Paraganglioma-Pheochromocytoma Syndrome","conceptCode":"C190373","definition":"A hereditary cancer syndrome characterized by the development of multiple paragangliomas including pheochromocytomas. It is caused by mutations in SDHA, SDHB, SDHC, SDHD, and SDHAF2 genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA3-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB2-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Familial Platelet Disorder and AML Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"7161776","version":"1","preferredName":"Familial Platelet Disorder with Associated Myeloid Malignancy","longName":"7161776","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the RUNX1 gene, encoding runt-related transcription factor 1. It is characterized by thrombocytopenia, abnormal platelet function, and a propensity to develop acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Familial Platelet Disorder with Associated Myeloid Malignancy","conceptCode":"C162696","definition":"An autosomal dominant condition caused by mutation(s) in the RUNX1 gene, encoding runt-related transcription factor 1. It is characterized by thrombocytopenia, abnormal platelet function, and a propensity to develop acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DDAE0B5-A704-3664-E053-F662850A71C9","latestVersionIndicator":"Yes","beginDate":"2020-02-05","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-02-05","modifiedBy":"ONEDATA","dateModified":"2020-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB3-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"6789030","version":"1","preferredName":"Hereditary Leiomyomatosis and Renal Cell Cancer","longName":"6789030","preferredDefinition":"An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to leiomyomas of the skin and uterus, renal cell carcinoma, and leiomyosarcoma of the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Leiomyomatosis and Renal Cell Carcinoma","conceptCode":"C51302","definition":"An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to renal cell carcinoma, leiomyomas of the skin and uterus, and leiomyosarcoma of the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BDAECC9-DB33-02E9-E053-F662850AABB5","latestVersionIndicator":"Yes","beginDate":"2019-06-21","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-21","modifiedBy":"ONEDATA","dateModified":"2019-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB4-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Lymphoproliferative Syndrome 1/ITK Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5207248","version":"1","preferredName":"ITK Deficiency","longName":"5207248","preferredDefinition":"A condition of decreased or absent presence or activity of IL2-inducible t-cell kinase. Deficiency of this protein is associated with lymphoproliferative syndrome 1, an autosomal recessive primary immunodeficiency characterized by onset in early childhood of Epstein-Barr virus (EBV)-associated immune dysregulation, manifest as lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, Hodgkin disease, and/or hypogammaglobulinemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoproliferative Syndrome 1","conceptCode":"C126344","definition":"An autosomal recessive immunodeficiency caused but mutation(s) in the ITK gene, encoding tyrosine-protein kinase ITK/TSK. It is characterized by the early childhood onset of Epstein-Barr virus (EBV)-associated immune dysregulation leading to lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, and/or hypogammaglobulinemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-44ED-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB5-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Peutz-Jeghers Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14758837","version":"1","preferredName":"Outer Hair Sheath and Infundibulum Neoplasm","longName":"14758837v1.00","preferredDefinition":"A neoplasm involving the outer hair sheath and infundibulum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outer Hair Sheath and Infundibulum Neoplasm","conceptCode":"C43324","definition":"A neoplasm involving the outer hair sheath and infundibulum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA4-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB6-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"SAMD9L-Related Myelodysplastic Syndrome Predisposition","valueDescription":null,"ValueMeaning":{"publicId":"14758838","version":"1","preferredName":"SAMD9L-Related Predisposition to Myelodysplastic Syndrome","longName":"14758838v1.00","preferredDefinition":"An autosomal dominant condition caused by mutation(s) in the SAMD9L gene, encoding sterile alpha motif domain-containing protein 9-like. It is characterized by an increased risk of developing myelodysplastic syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SAMD9L-Related Predisposition to Myelodysplastic Syndrome","conceptCode":"C178390","definition":"An autosomal dominant condition caused by mutation(s) in the SAMD9L gene, encoding sterile alpha motif domain-containing protein 9-like. It is characterized by an increased risk of developing myelodysplastic syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA5-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB7-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Schinzel-Giedion Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14758839","version":"1","preferredName":"Schinzel-Giedion Midface-Retraction Syndrome","longName":"14758839v1.00","preferredDefinition":"An autosomal dominant disorder associated with mutation(s) in the SETBP1 gene, encoding SET-binding protein. It is characterized by unique facial features, including midface hypoplasia, skeletal abnormalities, and mental retardation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schinzel-Giedion Midface-Retraction Syndrome","conceptCode":"C129308","definition":"An autosomal dominant disorder associated with mutation(s) in the SETBP1 gene, encoding SET-binding protein. It is characterized by unique facial features, including midface hypoplasia, skeletal abnormalities, and mental retardation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA6-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB8-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"WT1 Syndromes","valueDescription":null,"ValueMeaning":{"publicId":"14758840","version":"1","preferredName":"Wilms Tumor 1 Gene Syndromes","longName":"14758840v1.00","preferredDefinition":"A group of syndromes caused by autosomal dominant mutation(s) in the WT1 gene, encoding Wilms tumor protein. Patients with this mutation may have a predisposition to developing Wilms tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wilms Tumor 1 Gene Syndromes","conceptCode":"C131006","definition":"A group of syndromes caused by autosomal dominant mutation(s) in the WT1 gene, encoding Wilms tumor protein. Patients with this mutation may have a predisposition to developing Wilms tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"116CA974-3BA7-392B-E063-731AD00AC11A","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"116CA974-3BB9-392B-E063-731AD00AC11A","beginDate":"2024-02-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2024-02-15","modifiedBy":"SOKKERL","dateModified":"2024-02-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2789686","version":"1","preferredName":"Disease or Disorder Type","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Type; a subdivision of a particular kind of thing.","longName":"C2991:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"580AFD31-AE3B-5D1F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-29","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-29","modifiedBy":"ONEDATA","dateModified":"2008-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Incomplete","id":"F67DCEAD-E50B-53F5-E053-731AD00A02C8","latestVersionIndicator":"Yes","beginDate":"2023-03-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-09","modifiedBy":"SOKKERL","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":"12/27/23 pending addition, deletions, and updates per Nov 2023 PCDC-U of Chicago/Mei Li. jk 3/20/23 Updated qualifier. mr; 3/9/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173176","version":"1","longName":"Demographics","context":"Pediatric Cancer"},{"publicId":"12173188","version":"1","longName":"Medical History","context":"Pediatric Cancer"}]},{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594092","version":"1","longName":"Participant","context":"Pediatric Cancer"},{"publicId":"13596243","version":"1","longName":"Medical History","context":"Pediatric Cancer"}]},{"publicId":"13954630","version":"1","longName":"All Pediatric Core CDEs","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"14599258","version":"1","longName":"Diagnosis","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"CONDITION","type":"PCDC Alt Name","context":"Pediatric Cancer"},{"name":"medical_history_condition","type":"CCDI Alt Name","context":"Pediatric Cancer"},{"name":"Medical History Condition Type","type":"Ped Cancer Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Condition","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F7586D72-D398-5ABF-E053-731AD00A39AC","latestVersionIndicator":"Yes","beginDate":"2023-03-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-20","modifiedBy":"COLBERTM","dateModified":"2024-01-04","changeDescription":null,"administrativeNotes":"Correct Ped Cancer Alt Def entered as Alt name, moved to Alt Def. jk; 3/20/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}